Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies (FDB) is a world-leading contract development and manufacturing organization (CDMO) focused on the development and manufacture of biologics, vaccines, and advanced therapies. As a subsidiary of Fujifilm Holdings Corporation, the company operates a global network of state-of-the-art facilities in the U.S., U.K., and Denmark, providing end-to-end services from cell line development to commercial-scale production. The company is currently undergoing a massive global expansion, including a multi-billion dollar investment in Holly Springs, North Carolina, to create one of the largest end-to-end cell culture biopharmaceutical CDMO facilities in North America. FDB partners with major pharmaceutical companies like Regeneron and Novavax to manufacture life-saving treatments, including monoclonal antibodies and viral vectors.